L & F Laboratories SRL
L & F Laboratories reported total assets of €2.40m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Mar 2026).
By total assets for 2025, L & F Laboratories ranks among the 1,000 largest of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of L & F Laboratories shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +37 % Total assets +34 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
L & F Laboratories's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 31 Mar 2026
- Year ended 30 Sep 2024filed on 28 Mar 2025
- Year ended 30 Sep 2023filed on 29 Mar 2024
- Year ended 30 Sep 2022filed on 31 Mar 2023
- Year ended 30 Sep 2021filed on 29 Mar 2022
L & F Laboratories's financial analysis
- Solvency88.6%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of L & F Laboratories
L & F Laboratories's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0831.817.857
- VAT number
- BE0831817857
- Peppol
- Registered · 0208:0831817857 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Dec 2010
- Registered office
- 8620 Nieuwpoort
- Latest accounts
- 2025 · filed on 31 Mar 2026
- Activity
- Medical specialists activities (NACE 86220)
L & F Laboratories (SRL) has been based in Nieuwpoort since 2010, active in: medical specialists activities. For 2025, it reports a net profit of 359,998 € and equity of €2.12m; its revenue is not published. Its solvency stands at 88.6%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to L & F Laboratories
Companies in the same business, of comparable size and area, outside its group.
- Fidepark Antwerp · balance sheet €2.39m
- EFGE Manufacture of basic pharmaceutical products Genk · balance sheet €2.39m
- Gracobuild Other information service activities Waasmunster · balance sheet €2.40m
- Dr. Vinck - Dr. Delmotte Zemst · balance sheet €2.40m
- Cherpi Family Holding Brussels · balance sheet €2.39m
- Immo FSM Wavre · balance sheet €2.32m
Frequently asked questions about L & F Laboratories
What is the revenue of L & F Laboratories?
L & F Laboratories files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of L & F Laboratories?
In Belgium, the VAT number is the company number prefixed with BE: BE0831817857 for L & F Laboratories, if the company is VAT-registered. Its company number (CBE) is 0831.817.857.
Where is the registered office of L & F Laboratories?
According to the CBE register, the registered office of L & F Laboratories is in 8620 Nieuwpoort.
What is the equity of L & F Laboratories?
At the close of the 2025 financial year, the equity of L & F Laboratories amounts to 2,122,581 €, a solvency of 88.6% of total assets.
Who manages L & F Laboratories?
The register lists 1 active mandates at L & F Laboratories. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is L & F Laboratories within its sector?
By total assets for 2025, L & F Laboratories ranks among the 1,000 largest of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.
The full file of L & F Laboratories
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →